免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Omnipod® 胰島素管理系統,Omnipod DASH® 胰島素管理系統

K 號:K211575 · 2021-08-13

決定日期2021-08-13
產品代碼LZG
諮詢委員會醫療設備規範文本翻譯如下: HO 注意:原文中未提供具體的醫療設備規範文本,因此上述翻譯僅為示例。請提供完整的規範文本以便進行準確翻譯。
決定相當於

器材摘要

Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System is the device name listed in this FDA 510(k) record. The listed applicant is Insulet Corporation. It received FDA 510(k) clearance on 2021-08-13 under 510(k) number K211575. The device is classified under product code LZG. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System?

Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System is a medical device that received FDA 510(k) clearance on 2021-08-13. The listed applicant is Insulet Corporation. The 510(k) number is K211575.

When did Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System receive FDA 510(k) clearance?

Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System received FDA 510(k) clearance on 2021-08-13, under 510(k) number K211575.

Who is the listed applicant for Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System?

The FDA 510(k) record lists Insulet Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System?

The FDA product code for Omnipod® Insulin Management System, Omnipod DASH® Insulin Management System is LZG.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Insulet Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 19 項裝置 →

相關器械(代碼:LZG)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑